(Q34588955)

3 August 2017

1 reference

title

Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations (English)

1 reference

3 August 2017

0 references

1 reference

Mark A Frye

1

1 reference

PubMed ID

17156154

3 August 2017

Ihsan M Salloum

series ordinal

2

1 reference

3 August 2017

1 December 2006

1 reference

3 August 2017

1 reference

3 August 2017

8

1 reference

3 August 2017

6

1 reference

3 August 2017

677-685

1 reference

Adult disorders predicted by childhood conduct problems: results from the NIMH Epidemiologic Catchment Area project.

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Alcoholism and drug abuse in three groups--bipolar I, unipolars and their acquaintances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Characterizing female bipolar alcoholic patients presenting for initial evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

The effect of alcohol and substance abuse on the course of bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Complicated mania. Comorbidity and immediate outcome in the treatment of mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Incidence and significance of mixed affective states in a bipolar population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Prophylactic treatment of alcoholism by lithium carbonate. A controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Selection of initial treatment for bipolar disorder, manic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

The use of divalproex in alcohol relapse prevention: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Effects of topiramate in the treatment of alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Pharmacokinetic interactions of topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Quetiapine in bipolar disorder and cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Quetiapine for alcohol use and craving in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

Divalproex in the Treatment of Alcohol Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00370.X

10.1111/J.1399-5618.2006.00370.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

17156154